Structural Formula Of Verapamil Hydrochloride (Ver04 0000 01)
Verapamil Hydrochloride Injection
Product Images NDC 65219-384
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 65219-384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Ver04 0000 02)
Package Label (PRINCIPAL DISPLAY – Verapamil Hydrochloride Injection, USP 2 mL Vial Label)
This text provides information about a Verapamil Hydrochloride Injection in a 2 mL single-dose vial, with a concentration of 2.5 mg per mL. It is indicated for intravenous use only and should be protected from light. The packaging indicates it is for prescription use only, and includes a section for lot/expiry information.*
Package Label (PRINCIPAL DISPLAY – Verapamil Hydrochloride Injection, USP 2 mL Tray Label)
This is a description of Verapamil Hydrochloride Injection, USP in 5 mg per 2 mL single-dose vials for intravenous use only. Each mL contains 2.5 mg of verapamil hydrochloride USP, and sodium chloride. The solution may also contain hydrochloric acid and/or sodium hydroxide for pH adjustment. It is sterile, nonpyrogenic, and should be protected from light. Administered as a slow intravenous injection over at least two minutes, the unused portion should be discarded. The usual dosage information should be accessed from the package insert. Store between 20°C to 25°C, protect from light until use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
